A pioneer in its field, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the non-invasive gold standard solution for comprehensive management of liver health. FibroScan® is recognized worldwide as the reference for liver fibrosis and liver steatosis assessment with more than 6,270+ peer-reviewed publications and 250+ international guidelines recommendations. Echosens has made FibroScan® available in over 140+ countries enabling millions of liver examinations worldwide. We are working hand in hand with physicians, medical academic research, pharmaceutical companies for patient identification and monitoring in MASLD/MASH. As patient education is a major issue, we have created the "myliverexam" website that provides information about the role of the liver and why it is vital to the global health.
Looking for a particular Echosens employee's phone or email?
Echosens Questions
The Echosens annual revenue was $80.4 million in 2026.
Laurent Sandrin is the Chairman and Chief Science and Innovation Officer of Echosens.
310 people are employed at Echosens.
Echosens is based in Paris, Île-de-France.
The NAICS codes for Echosens are [334, 339, 33].
The SIC codes for Echosens are [384, 38, 30, 308].
Top Echosens Employees
-
35+
-
22
-
2
-
Capucine Chambard Quil
Vice President, Pharma at Echosens
Île-de-France, France42 -
Brian Sanders
Vice President of Sales, North America at Echosens
St. Louis, MO, US44
Related Companies
